341 related articles for article (PubMed ID: 6887930)
1. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
Salmon J; Coussediere D; Cousty C; Raynaud JP
J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of moxestrol in humans.
Salmon J; Coussediere D; Cousty C; Raynaud JP
J Steroid Biochem; 1983 May; 18(5):565-73. PubMed ID: 6855232
[TBL] [Abstract][Full Text] [Related]
3. Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals.
Düsterberg B; Kühne G; Täuber U
Arzneimittelforschung; 1986 Aug; 36(8):1187-90. PubMed ID: 3778555
[TBL] [Abstract][Full Text] [Related]
4. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
Timchalk C; Nolan RJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
Krause W; Kühne G
Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog.
Pellegatti M; Grossi P; Ayrton J; Evans GL; Harker AJ
Xenobiotica; 1990 Aug; 20(8):765-77. PubMed ID: 2219960
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
[TBL] [Abstract][Full Text] [Related]
14. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
Tse FL; Orwig B; Jaffe JM
Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
[TBL] [Abstract][Full Text] [Related]
15. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.
Chadwick M; Silveira DM; MacGregor JA; Branfman AR; Liss RH; Yesair DW
Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806
[TBL] [Abstract][Full Text] [Related]
16. Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man.
Scatina JA; Hicks DR; Kraml M; Cayen MN
Eur J Drug Metab Pharmacokinet; 1990; 15(1):37-48. PubMed ID: 2384116
[TBL] [Abstract][Full Text] [Related]
17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of amezinium in rat and dog.
Traut M; Brode E; Neumann B; Kummer H
Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
[TBL] [Abstract][Full Text] [Related]
19. Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.
Goldzieher JW
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):318-22. PubMed ID: 2196804
[TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]